Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beylot-Barry

Showing results (211-220 of 247) with videos related to

Pageof 25
Sort By:
Cancer Immunology, Immunotherapy : CII|March 19, 2022
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitorsE Gefard-Gontier, R Markich, M Zysman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2018
Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » studyM-A Richard, F Corgibet, M Beylot-Barry, et al.
The British Journal of Dermatology|February 4, 2015
Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 casesA Fauconneau, A Pham-Ledard, D Cappellen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
ESMO Open|October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM databaseA Bassompierre, S Dalac, B Dreno, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
The British Journal of Dermatology|September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013E Sbidian, C Hotz, J Seneschal, et al.
The American Journal of Surgical Pathology|October 19, 1999
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 casesM Beylot-Barry, B Vergier, B Masquelier, et al.
The American Journal of Surgical Pathology|October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 casesB Vergier, M Beylot-Barry, K Pulford, et al.
Pageof 25

Showing results (211-220 of 247) with videos related to

Sort By:
Pageof 25
Cancer Immunology, Immunotherapy : CII|March 19, 2022
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitorsE Gefard-Gontier, R Markich, M Zysman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 24, 2018
Sex- and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » studyM-A Richard, F Corgibet, M Beylot-Barry, et al.
The British Journal of Dermatology|February 4, 2015
Assessment of diagnostic criteria between primary cutaneous anaplastic large-cell lymphoma and CD30-rich transformed mycosis fungoides; a study of 66 casesA Fauconneau, A Pham-Ledard, D Cappellen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
The British Journal of Dermatology|May 8, 2013
Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patientsF Julia, T Petrella, M Beylot-Barry, et al.
ESMO Open|October 24, 2021
Efficacy of sonic hedgehog inhibitors rechallenge, after initial complete response in recurrent advanced basal cell carcinoma: a retrospective study from the CARADERM databaseA Bassompierre, S Dalac, B Dreno, et al.
Blood|May 26, 1999
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous LymphomasF Grange, G Hedelin, P Joly, et al.
The British Journal of Dermatology|September 26, 2015
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013E Sbidian, C Hotz, J Seneschal, et al.
The American Journal of Surgical Pathology|October 19, 1999
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 casesM Beylot-Barry, B Vergier, B Masquelier, et al.
The American Journal of Surgical Pathology|October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 casesB Vergier, M Beylot-Barry, K Pulford, et al.
Pageof 25